PRA’s track record of successful delivery of global clinical trial projects is due to a policy of recruiting only “best in class” investigators. This is of utmost importance to your study as investigators not only enable access to suitable subjects but are also custodians of data quality and ethical integrity. Maintaining the quality standard of investigators not only safeguards your study, data and ethics but also allows us to develop useful global networks by increasing the participation of emerging countries with relatively nascent clinical trial environments.
PRA’s Investigator Relations group supports the delivery of global clinical trials with the following activities:
- Identifies and recruits “best in class” investigators
- Builds sustainable relationships with quality sites and investigator networks by implementing effective working practices and providing site-level support
- Builds and maintains global “best in class” investigator database
- Develops proactive relationships with upcoming, 2nd-tier investigative sites in emerging markets
- Enables selection of appropriate investigators for global feasibility assessment and clinical projects
- Provides access to therapeutic leaders in emerging markets for current information on standard of care
- Understands current operational practices in emerging regions
